ERBB2 and breast cancer: Many prognostic and predictive biomarkers are utilized in BC, among which the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) have been validated and are currently used in routine clinical practice for decision-making regarding specific treatments in BC [8].